Investing Profile

Daniel Coley

CEO
Investing in B2B software in the Southeast US
Photo of Daniel Coley, Investor at Cofounders Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Babson College Network
38 CONNECTIONS
$250K - $2.0M
$1M
14
CompanyStageDateRound SizeTotal Raised
TEDU
SeedAug 2024$2M
$2M
Ecomap
Seed-2Aug 2023$3.5
$3.5
Mercy BioAnalytics
Series AApr 2023$41M
$41M
Alpheus Medical
Series ANov 2022$14M
$82M
Co-investors: Conrad Wang (OrbiMed), Klaus Veitinger (OrbiMed), Imran Eba (Action Potential Venture Capital)
Naveris
Series ASep 2022$33M
$33M
Auron Therapeutics
Series AJul 2022$48M
$88M
Co-investors: Eric Shiozaki (DCVC (Data Collective)), Alexandra Cantley (Polaris Partners), Marianne Mertens (Apollo Health Ventures), Isaac Ciechanover
Lunit
Pre-IPO RoundNov 2021$26M
$87M
Co-investors: Garheng Kong (HealthQuest Capital)
Immunitas Therapeutics
Series BAug 2021$58M
$97M
Co-investors: Lucio Iannone (Leaps by Bayer), Geeta Vemuri (Agent Capital), Christoph Westphal (Longwood Fund), Brian Halak (Medical Excellence Capital, LLC), Laura Brass (MPM BioImpact)
B2B Software and SaaS
Crypto or biotech or cyber security
Associate BrightEdge (American Cancer Society Impact Fund)2019 - 2023
Analyst SunTrust Robinson Humphrey2018 - 2019
Babson College B.S.